What is the right dose? The elusive optimal biologic dose in phase I clinical trials

Alex A. Adjei

doi:10.1200/JCO.2006.07.4658

What is the right dose? The elusive optimal biologic dose in phase I clinical trials

Alex A. Adjei

Medical Oncology

Research output: Contribution to journal › Editorial › peer-review

55 Scopus citations

Original language	English (US)
Pages (from-to)	4054-4055
Number of pages	2
Journal	Journal of Clinical Oncology
Volume	24
Issue number	25
DOIs	https://doi.org/10.1200/JCO.2006.07.4658
State	Published - Sep 1 2006

ASJC Scopus subject areas

Oncology
Cancer Research

Access to Document

10.1200/JCO.2006.07.4658

Cite this

@article{23e79c0e39234904a08e90c8594636e1,

title = "What is the right dose? The elusive optimal biologic dose in phase I clinical trials",

author = "Adjei, {Alex A.}",

year = "2006",

month = sep,

day = "1",

doi = "10.1200/JCO.2006.07.4658",

language = "English (US)",

volume = "24",

pages = "4054--4055",

journal = "Journal of Clinical Oncology",

issn = "0732-183X",

publisher = "American Society of Clinical Oncology",

number = "25",

}

TY - JOUR

T1 - What is the right dose? The elusive optimal biologic dose in phase I clinical trials

AU - Adjei, Alex A.

PY - 2006/9/1

Y1 - 2006/9/1

UR - http://www.scopus.com/inward/record.url?scp=33748652419&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=33748652419&partnerID=8YFLogxK

U2 - 10.1200/JCO.2006.07.4658

DO - 10.1200/JCO.2006.07.4658

M3 - Editorial

C2 - 16943522

AN - SCOPUS:33748652419

SN - 0732-183X

VL - 24

SP - 4054

EP - 4055

JO - Journal of Clinical Oncology

JF - Journal of Clinical Oncology

IS - 25

ER -

What is the right dose? The elusive optimal biologic dose in phase I clinical trials

ASJC Scopus subject areas

Access to Document

Other files and links

Cite this